NasdaqGS - Delayed Quote USD
Enliven Therapeutics, Inc. (ELVN)
20.74
-0.63
(-2.95%)
At close: June 6 at 4:00:01 PM EDT
20.74
0.00
(0.00%)
After hours: June 6 at 4:04:04 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -0.37 | -0.4 | -1.59 | -1.64 |
| Low Estimate | -0.37 | -0.4 | -1.59 | -1.64 |
| High Estimate | -0.37 | -0.4 | -1.59 | -1.64 |
| Year Ago EPS | -- | -0.48 | -1.91 | -1.59 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 7 | 7 |
| Avg. Estimate | -- | -- | 7.14k | 7.14k |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | 50k | 50k |
| Year Ago Sales | -- | -- | -- | 7.14k |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.56 | -0.5 | -0.52 | -0.5 |
| EPS Actual | -0.41 | -0.48 | -0.46 | -0.57 |
| Difference | 0.15 | 0.02 | 0.06 | -0.07 |
| Surprise % | 27.05% | 4.36% | 11.11% | -13.03% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.37 | -0.4 | -1.59 | -1.64 |
| 7 Days Ago | 0 | 0 | -2.14 | 0 |
| 30 Days Ago | 0 | 0 | -2.14 | 0 |
| 60 Days Ago | 0 | 0 | -2.14 | 0 |
| 90 Days Ago | 0 | 0 | -2.14 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ELVN | -- | 16.35% | 16.75% | -3.14% |
| S&P 500 | 13.13% | 2.48% | 7.55% | 14.01% |
Upgrades & Downgrades
| Maintains | Jones Trading: Buy to Buy | 5/16/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 5/15/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 3/21/2025 |
| Initiated | BTIG: Buy | 12/13/2024 |
| Maintains | Baird: Outperform to Outperform | 11/15/2024 |
| Initiated | Jones Trading: Buy | 10/31/2024 |
Related Tickers
ENTA Enanta Pharmaceuticals, Inc.
7.47
+3.61%
NUVL Nuvalent, Inc.
78.02
-0.09%
TYRA Tyra Biosciences, Inc.
10.55
+3.74%
CNTA Centessa Pharmaceuticals plc
11.92
+0.51%
PTGX Protagonist Therapeutics, Inc.
54.38
+1.04%
MLYS Mineralys Therapeutics, Inc.
16.12
+3.20%
ERAS Erasca, Inc.
1.6000
+1.91%
PRAX Praxis Precision Medicines, Inc.
44.56
+5.44%
JBIO Jade Biosciences, Inc.
7.19
+4.35%
BCAX Bicara Therapeutics Inc.
11.50
+4.26%